4//SEC Filing
Chopas James George 4
Accession 0001127602-25-021110
CIK 0001492422other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 1:06 PM ET
Size
4.5 KB
Accession
0001127602-25-021110
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-02$28.08/sh−548$15,386→ 53,657 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on August 29, 2025.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001836430
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 1:06 PM ET
- Size
- 4.5 KB